AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23616163
Drug: Low-dose propranolol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose propranolol (20 mg)
Trial: 23616163
Drug: High-dose propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose propranolol (80 mg)
Trial: 21672315
Drug: tamsulosin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tamsulosin 0.2 mg orally once daily for 4 weeks
Trial: 21672315
Drug: silodosin 4
RxNorm normalized name: silodosin 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: silodosin 4 mg orally twice daily for 4 weeks
Trial: 19114862
Drug: tipranavir/ritonavir (TPV/r)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tipranavir/ritonavir (TPV/r) 500/200 mg twice daily (b.i.d.)
Trial: 12590854
Drug: 4% boric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% boric acid solution in alcohol and frequent suction cleaning of the ear canal
Trial: 12590854
Drug: tioconazole ointment
RxNorm normalized name: TIOCONAZOLE 65 mg in 1 g VAGINAL OINTMENT [TIOCONAZOLE OINTMENT 6.5%]
DrugBank: Tioconazole (DB01007)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: tioconazole ointment
Trial: 10487457
Drug: BMV lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMV lotion
Trial: 7202249
Drug: Trimethoprim (TMP),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim (TMP), 300 mg once a day for seven days (group 1)
Trial: 7202249
Drug: Trimethoprim (TMP),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim (TMP), 200 mg once a day for 10 days (group 2)
Trial: 7202249
Drug: Nitrofurantoin, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrofurantoin, 100 mg four times a day for 10 days (group 3)
Trial: 18773686
Drug: Conservative drug
RxNorm normalized name: Conserved dopamine neurotrophic factor
DrugBank: HER-902 (DB17948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative drug therapy + Su Jok therapy with laser ray at acupuncture points
Trial: 21478141
Drug: Conservative drug
RxNorm normalized name: Conserved dopamine neurotrophic factor
DrugBank: HER-902 (DB17948)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative drug therapy only
Trial: 16216060
Drug: Azosemide (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azosemide (30 mg/d for cardiac/renal edema; 60 mg/d for hepatogenic edema)
Trial: 16216060
Drug: Furosemide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (20 mg/d for cardiac/renal edema; 40 mg/d for hepatogenic edema)
Trial: 14693730
Drug: Total testosterone:sex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total testosterone:sex hormone binding globulin ratio
Trial: 10507606
Drug: Fenoldopam 0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoldopam 0.03 µg/kg/min
Trial: 10507606
Drug: Fenoldopam 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoldopam 0.1 µg/kg/min
Trial: 10507606
Drug: Fenoldopam 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoldopam 0.3 µg/kg/min
Trial: 7138727
Drug: Oral diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam alone
Trial: 7138727
Drug: Oral diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam with atropine
Trial: 7138727
Drug: Oral diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam with hyoscine
Trial: 31852287
Drug: Isosorbide mononitrate
RxNorm normalized name: Isosorbide Mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide mononitrate (IMN) plus 25 µg sublingual misoprostol
Trial: 27684379
Drug: Immediate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate treatment for patients with two consecutive viraemia episodes below 3000 genomes/ml
Trial: 27684379
Drug: Monitoring for
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Monitoring for patients with two consecutive viraemia episodes below 3000 genomes/ml
Trial: 27684379
Drug: Stopping treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stopping treatment when viraemia is less than 200 genomes/ml
Trial: 27684379
Drug: Stopping treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stopping treatment when viraemia is less than 3000 genomes/ml
Trial: 18753005
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of tricyclic antidepressants (TCAs)
Trial: 18753005
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of selective serotonin reuptake inhibitors (SSRIs)
Trial: 1755638
Drug: Intermittent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent treatment for covert bacteriuria for the first four years
Trial: 6352366
Drug: pirprofen 400
RxNorm normalized name: Carprofen
DrugBank: Carprofen (DB00821)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: pirprofen 400 mg b.i.d.
Trial: 6352366
Drug: indomethacin 50
RxNorm normalized name: indomethacin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: indomethacin 50 mg b.i.d.
Trial: 29729427
Drug: Prednisolone (PRED)
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone (PRED) 7.5 mg once daily (n=12)
Trial: 29729427
Drug: Prednisolone (PRED)
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone (PRED) 30 mg once daily (n=12)
Trial: 30496870
Drug: Live attenuated
RxNorm normalized name: mumps, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live attenuated hepatitis A vaccine (HA-L)
Trial: 30496870
Drug: Inactivated hepatitis
RxNorm normalized name: Inactivated hepatitis A vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated hepatitis A vaccine (HA-I)
Trial: 20442102
Drug: Tumescence treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tumescence treatment
Trial: 20442102
Drug: Cannulation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannulation treatment
Trial: 12168923
Drug: Octreotide 600-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 600-800 microg/day and chlorpromazine (15-25 mg/day)
Trial: 12168923
Drug: Hyoscine butylbromide
RxNorm normalized name: Hyoscine butylbromide
DrugBank: Butylscopolamine (DB09300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine butylbromide 60-80mg/day and chlorpromazine (15-25 mg/day)
Trial: 8583349
Drug: Pressurized metered‐dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pressurized metered‐dose aerosol inhaler (125 micrograms per dose)
Trial: 8583349
Drug: Novel mechanical
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel mechanical pump spray device (500 micrograms per dose)
Trial: 2714067
Drug: Clindamycin (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin (900 mg Q8H) and Gentamicin (3-5 mg/kg/day in divided doses Q8H)
Trial: 788731
Drug: Indomethacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (200 mg daily)
Trial: 19427180
Drug: Danhong Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danhong Injection (DHI) administered intravenously
Trial: 12934420
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (2 mg/kg) administered 1 min before intubation
Trial: 12934420
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (2 mg/kg) administered 3 min before intubation
Trial: 12934420
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (2 mg/kg) administered 5 min before intubation
Trial: 12934420
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (2 mg/kg) administered 10 min before intubation
Trial: 11128559
Drug: Amoxycillin 45
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 45 mg/kg/day b.d.
Trial: 11128559
Drug: Amoxycillin 40
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 40 mg/kg/day t.d.s.
Trial: 9129069
Drug: Ganciclovir 8
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ganciclovir 8 mg/kg/day
Trial: 9129069
Drug: Ganciclovir 12
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ganciclovir 12 mg/kg/day
Trial: 7949548
Drug: Serum creatinine
RxNorm normalized name: Creatinine
DrugBank: Creatinine (DB11846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum creatinine < 1.7 mg/dl at the time of steroid withdrawal
Trial: 3668883
Drug: GSR biofeedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSR biofeedback training (minimally effective treatment control)
Trial: 31840339
Drug: FITNET-NHS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FITNET-NHS treatment
Trial: 29989107
Drug: 6‐mm implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6‐mm implants (experimental)
Trial: 29989107
Drug: 10‐mm implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10‐mm implants with vertical augmentation (control)
Trial: 28963315
Drug: Current standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current standard therapy
Trial: 23545101
Drug: Intravesical gemcitabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical gemcitabine (2,000 mg/50 cc weekly for 6 weeks, maintenance monthly for 1 year)
Trial: 23545101
Drug: 1/3 dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1/3 dose Bacillus Calmette‐Guérin (weekly for 6 weeks, maintenance 3 weekly instillations at 3, 6 and 12 months)
Trial: 19553063
Drug: Behavioral couples
RxNorm normalized name: IMMUNOGLOBULIN G4-KAPPA/G4-LAMBDA, ANTI-(HOMO SAPIENS GPRC5D (G PROTEIN-COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D)), AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY, BISPECIFIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral couples therapy (BCT) plus individual‐based treatment (IBT)
Trial: 19553063
Drug: Individual‐based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual‐based treatment (IBT) only
Trial: 16423517
Drug: Puffs of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Puffs of beta 2 agonist (salbutamol 50 microg/kg or terbutaline 125 microg/kg) via spacer
Trial: 9264427
Drug: Oral L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral L-arginine (6 g/day for 3 days)
Trial: 8908436
Drug: Ciprofloxacin ophthalmic
RxNorm normalized name: ciprofloxacin ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin ophthalmic solution 0.3%
Trial: 8353434
Drug: Chloramphenicol ophthalmic
RxNorm normalized name: chloramphenicol ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloramphenicol ophthalmic solution 0.5%
Trial: 28771070
Drug: Office-based physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Office-based physical therapy (OBPT)
Trial: 23321194
Drug: Gabapentin 900
RxNorm normalized name: gabapentin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 900 mg orally 2 hours before surgery
Trial: 18195263
Drug: [(18)F]fluoro‐l‐dopa uptake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: [(18)F]fluoro‐l‐dopa uptake in TLE patients
Trial: 18195263
Drug: Glucose metabolism
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose metabolism assessment in TLE patients
Trial: 10824634
Drug: Low-dose pirenzepine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose pirenzepine (0.5 mg intravenous bolus followed by continuous infusion of 0.15 microg/kg/min)
Trial: 10824634
Drug: Transdermal scopolamine
RxNorm normalized name: Transderm Scop
DrugBank: Scopolamine (DB00747)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal scopolamine treatment
Trial: 8420815
Drug: Picotamide (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Picotamide (900 mg/day) in normal subjects
Trial: 20875504
Drug: Action observation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Action observation treatment (AOT) in addition to conventional physiotherapy
Trial: 12720616
Drug: Metered dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered dose inhaler training
Trial: 1844694
Drug: Component therapies
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Component therapies
Trial: 26906713
Drug: Pasireotide LAR
RxNorm normalized name: pasireotide LAR 20 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide LAR 40 mg and 60 mg
Trial: 27423779
Drug: Lanreotide Autogel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanreotide Autogel 120 mg
Trial: 20681235
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine (CMG)
Trial: 15598196
Drug: Methadone plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone plus injectable heroin or methadone plus inhalable heroin prescribed over 12 months (heroin maximum 1000 mg per day, methadone maximum 150 mg per day)
Trial: 15598196
Drug: Heroin-assisted treatment
RxNorm normalized name: heroin
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin-assisted treatment (previously participated in abstinence-oriented treatment)
Trial: 15598196
Drug: Methadone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone treatment (previously participated in abstinence-oriented treatment)
Trial: 15598196
Drug: Heroin-assisted treatment
RxNorm normalized name: heroin
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin-assisted treatment (no experience in abstinence-oriented treatment)
Trial: 15598196
Drug: Methadone maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone maintenance treatment (no experience in abstinence-oriented treatment)
Trial: 11051015
Drug: Low-dose ESWT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ESWT (3 x 5000 impulses, no anesthesia)
Trial: 11051015
Drug: High-dose ESWT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ESWT (1 x 5000 impulses, intravenous analgesia)
Trial: 19517101
Drug: CPG-DDS plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPG-DDS plus 1 mg/kg/day artesunate
Trial: 19517101
Drug: CPG-DDS plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPG-DDS plus 2 mg/kg/day artesunate
Trial: 19517101
Drug: CPG-DDS plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPG-DDS plus 4 mg/kg/day artesunate
Trial: 19517101
Drug: CPG-DDS alone
RxNorm normalized name: DDS
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CPG-DDS alone (2/2.5 mg/kg/day)
Trial: 17355738
Drug: Rivastigmine treatment
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine treatment (3 mg/day to 9 mg/day over time)
Trial: 17355738
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (maintained on current antipsychotic medication)
Trial: 7523735
Drug: Prostate cancer
RxNorm normalized name: Leuprolide Acetate 22.5mg Lyophilisate for suspension for injection [Prostate Cancer] with Diluent, Transfer Device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostate cancer screening using prostate specific antigen and digital rectal examination
Trial: 26591681
Drug: Massage treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage treatment 1 and 2
Trial: 26591681
Drug: Basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatment 1 and 2
Trial: 20349353
Drug: Patients receiving
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients receiving cancer treatment
Trial: 20349353
Drug: Patients awaiting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients awaiting new treatment
Trial: 20349353
Drug: Patients on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients on surveillance or whose treatment had been stopped
Trial: 19004162
Drug: Weight-loss supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight-loss supplement
Trial: 19004162
Drug: Both supplement
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both supplement and coaching
Trial: 12212248
Drug: Low volume
RxNorm normalized name: CONNECTOR,LOW VOLUME,ENFIT MOOG INFINITY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low volume ventilation (tidal volume 6-8 ml.kg-1)
Trial: 12212248
Drug: Normal volume
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal volume ventilation (tidal volume 12-14 ml.kg-1)
Trial: 8941026
Drug: Didanosine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine (300 mg) administered orally and intravenously
Trial: 8941026
Drug: Didanosine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine (300 mg) administered orally 4 hours before hemodialysis
Trial: 14621771
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) 10 mg/kg per day
Trial: 3932470
Drug: Dobutamine infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dobutamine infusions
Trial: 14671236
Drug: Saline infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusions (control)
Trial: 27062041
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplementation (250 mg)
Trial: 22812731
Drug: Continuous positive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous positive airways pressure treatment for patients with obstructive sleep-disordered breathing (apnea hypopnea index ≥20)
Trial: 22812731
Drug: Continuous positive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous positive airways pressure treatment
Trial: 19266407
Drug: Bonding social
RxNorm normalized name: SKIN BOND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bonding social capital (treatment and emotional buddy)
Trial: 16114155
Drug: Crinone gel
RxNorm normalized name: Crinone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Crinone gel (n=36)
Trial: 11799502
Drug: 0.1% ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% ropivacaine with 2 microg/mL fentanyl (group RF, n = 20)
Trial: 1941733
Drug: Rioprostil, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rioprostil, 300 micrograms twice daily for 12 weeks
Trial: 28407735
Drug: Telbivudine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telbivudine treatment starting at 12 weeks (Group A; n=62)
Trial: 28407735
Drug: Telbivudine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telbivudine treatment starting at 20-28 weeks (Group B; n=61)
Trial: 28407735
Drug: No antiviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antiviral treatment (Group C; n=65)
Trial: 19852303
Drug: Guilong Tongluo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guilong Tongluo Capsule (GTC) combined with prednisone
Trial: 15102339
Drug: S-adenosylmethionine (SAMe)
RxNorm normalized name: S-adenosylmethionine
DrugBank: Ademetionine (DB00118)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-adenosylmethionine (SAMe) 1200 mg
Trial: 15102339
Drug: Celecoxib (Celebrex)
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib (Celebrex) 200 mg
Trial: 14504565
Drug: l-tryptophan
RxNorm normalized name: L-tryptophan
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: l-tryptophan
Trial: 361988
Drug: Prazosin and
RxNorm normalized name: prazosin and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin and diuretics
Trial: 361988
Drug: Clonidine and
RxNorm normalized name: clonidine and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine and diuretics
Trial: 21377168
Drug: Hybrid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid treatment (SCST and neurocognitive remediation)
Trial: 19646443
Drug: Lanreotide (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanreotide (120 mg) administered every 28 days for 24 weeks
Trial: 11318525
Drug: 3 MU
RxNorm normalized name: Orasep Reformulated Dec 2013 Mucosal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 MU of IFN‐beta twice daily for four weeks (group A)
Trial: 9007770
Drug: Short CPM
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short CPM duration (3-5 hours per day) with CPM ROM increased 5 degrees twice daily